tiprankstipranks

Memphasys Appoints Marjan Mikel as Non-Executive Director to Boost Global Expansion

Story Highlights
Memphasys Appoints Marjan Mikel as Non-Executive Director to Boost Global Expansion

Don’t Miss TipRanks’ Half-Year Sale

Memphasys Ltd ( (AU:MEM) ) has shared an update.

Memphasys Limited has appointed Marjan Mikel as a Non-Executive Director, bringing extensive experience in business development and commercialisation across the Medtech, diagnostics, healthcare services, and life sciences sectors. Mikel’s previous roles and familiarity with Memphasys’ strategic vision are expected to aid the company’s global expansion of its Felix™ system and accelerate the commercialisation of the RoXsta™ platform.

More about Memphasys Ltd

Memphasys Limited (ASX: MEM) is a biotechnology company specializing in advanced reproductive biotechnology. The company develops medical devices, diagnostics, and proprietary media for human and animal applications, with flagship technologies like the Felix™ and RoXsta™ Systems aimed at enhancing fertility outcomes worldwide.

Average Trading Volume: 52,211,380

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$7.93M

See more insights into MEM stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1